文献速递心胸血管麻醉

气相扩散不限制肺挥发性麻醉药摄取速率

Gas Phase Diffusion Does Not Limit Lung Volatile Anesthetic Uptake Rate.
PubMed 文献 · Anesthesiology · 2022-01-01

该研究在17例体外循环前的心脏手术麻醉患者中,比较了血气溶解度相似但分子量不同的地氟烷和氧化亚氮的呼气末-动脉分压梯度。结果显示地氟烷的(PetG-PaG)/FiG显著小于氧化亚氮,校正摄取率后仍小于预设的20%阈值,提示气相纵向分层未对地氟烷肺摄取造成临床显著额外的扩散限制。

要点

  • 地氟烷的呼气末-动脉分压梯度相对吸入浓度显著小于氧化亚氮。
  • 校正摄取率差异后,地氟烷的梯度仍低于20%生理显著阈值。
  • 未发现支持地氟烷相对氧化亚氮存在临床显著气相扩散限制的证据。

核心结论

  • 在测得的呼气末-动脉分压梯度和肺泡死腔方面,未发现支持地氟烷相对氧化亚氮存在临床显著额外扩散限制的证据。

研究设计与样本

  • 研究纳入17例接受心脏手术、体外循环前麻醉通气的患者,同时给予地氟烷(吸入浓度2-3%)和氧化亚氮(吸入浓度10-15%)。
  • 同步测量潮气气体浓度、动脉与混合静脉血分压(顶空平衡法),并用直接Fick法结合热稀释心输出量计算摄取速率。

主要发现

  • 地氟烷的(PetG-PaG)/FiG均值(SD)为0.86(0.37)mmHg,显著小于氧化亚氮的1.65(0.58)mmHg(P < 0.0001)。
  • 地氟烷的肺泡死腔也小于氧化亚氮。
  • 校正两种气体摄取速率差异后,地氟烷的(PetG-PaG)/FiG为1.62(0.61)mmHg,仍低于氧化亚氮的1.98(0.69)mmHg(P = 0.028),且小于预设的20%阈值。

关键数值与推荐

  • 预设生理显著阈值:地氟烷相对氧化亚氮的(PetG-PaG)/FiG增大20%。
  • 地氟烷(PetG-PaG)/FiG:0.86(0.37)mmHg;氧化亚氮:1.65(0.58)mmHg;P < 0.0001。
  • 校正后地氟烷:1.62(0.61)mmHg;氧化亚氮:1.98(0.69)mmHg;P = 0.028。

临床怎么用

  • 对于地氟烷等挥发性麻醉药,肺摄取效率主要受通气/血流比例失调影响,气相扩散限制的临床意义不大。

局限性

  • 研究样本量较小(17例),且仅在心脏手术体外循环前患者中开展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inefficiency of lung gas exchange during general anesthesia is reflected in alveolar (end-tidal) to arterial (end-tidal-arterial) partial pressure gradients for inhaled gases, resulting in an increase in alveolar deadspace. Ventilation-perfusion mismatch is the main contributor to this, but it is unclear what contribution arises from diffusion limitation in the gas phase down the respiratory tree (longitudinal stratification) or at the alveolar-capillary barrier, especially for gases of high molecular weight such as volatile anesthetics. METHODS: The contribution of longitudinal stratification was examined by comparison of end-tidal-arterial partial pressure gradients for two inhaled gases with similar blood solubility but different molecular weights: desflurane and nitrous oxide, administered together at 2 to 3% and 10 to 15% inspired concentration (FiG), respectively, in 17 anesthetized ventilated patients undergoing cardiac surgery before cardiopulmonary bypass. Simultaneous measurements were done of tidal gas concentrations, of arterial and mixed venous blood partial pressures by headspace equilibration, and of gas uptake rate calculated using the direct Fick method using thermodilution cardiac output measurement. Adjustment for differences between the two gases in FiG and in lung uptake rate (VG) was made on mass balance principles. A 20% larger end-tidal-arterial partial pressure gradient relative to inspired concentration (PetG - PaG)/FiG for desflurane than for N2O was hypothesized as physiologically significant. RESULTS: Mean (SD) measured (PetG - PaG)/FiG for desflurane was significantly smaller than that for N2O (0.86 [0.37] vs. 1.65 [0.58] mmHg; P < 0.0001), as was alveolar deadspace for desflurane. After adjustment for the different VG of the two gases, the adjusted (PetG - PaG)/FiG for desflurane remained less than the 20% threshold above that for N2O (1.62 [0.61] vs. 1.98 [0.69] mmHg; P = 0.028). CONCLUSIONS: No evidence was found in measured end-tidal to arterial partial pressure gradients and alveolar deadspace to support a clinically significant additional diffusion limitation to lung uptake of desflurane relative to nitrous oxide.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Peyton PJ. Gas Phase Diffusion Does Not Limit Lung Volatile Anesthetic Uptake Rate. Anesthesiology. 2022. PMID: 35503977. doi:10.1097/ALN.0000000000004260

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。